Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation ...

Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles ...

Danaher Corporation beats earnings expectations. Reported EPS is $2.02, expectations were $1.84. Operator: Good morning. My name is Todd, and I will be your conference facilitator today.

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...

Danaher Corporation incorporates science and technology and has a market cap of $150B. The company has mixed financials, with its gross profit margin being its strongest and most consistent.

The industry as a whole closed the day down 0.2%. By the end of trading, Danaher Corporation fell $1.02 (-1.6%) to $63.68 on average volume. Throughout the day, 3,164,346 shares of Danaher ...

Danaher Corporation (NYSE:DHR) Executive Vice President Julie Sawyer Montgomery highlighted the goal of increasing access to precision medicines so that no patients are left behind, while ...